Indolinone derivatives
US7223783B2 · kind B2 · utility
0Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2006 |
| Grant date | May 29, 2007 |
| Priority date | — |
| Expiry date | Feb 21, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I)in which R1, R2, R3 and R4 have the meanings given in the specification, are receptor tyrosine kinase inhibitors useful in the treatment of proliferative disorders, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.